Another fantastic event in the books! Thanks to all who joined us this week at World Drug Safety Congress Americas - whether you attended our keynote fireside chat, heard from industry experts in our keynote panel session, stopped by our booth to discover LifeSphere solutions, or joined us for libations and networking at #AGAfterHours, we were thrilled to connect with so many industry leaders in Boston. The future of Safety is bright! 📸 #WorldDrugSafetyUS #WorldDrugSafety #lifesciences #pv #pharmacovigilance
ArisGlobal
Software Development
Waltham, Massachusetts 110,890 followers
Innovative Cloud Solutions for Drug Safety, Data & Analytics, Regulatory and Medical Affairs.
About us
ArisGlobal is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans almost 40 years, LifeSphere® boosts efficiency, ensures compliance, and reduces cost through multi-tenant Software-as-a-Service (SaaS) architecture. Headquartered in Waltham, MA. ArisGlobal has regional offices in Europe, India, Japan, and China.
- Website
-
https://www.arisglobal.com
External link for ArisGlobal
- Industry
- Software Development
- Company size
- 1,001-5,000 employees
- Headquarters
- Waltham, Massachusetts
- Type
- Privately Held
- Founded
- 1987
- Specialties
- Pharmacovigilance, Safety Analytics Solution, Signal Detection & Risk Management, ICSR, Regulatory Information Management, eCTD publishing, Regulatory Analytics, ISO IDMP Solution, Regulatory Submissions Tracking, Clinical Data Management (RTSM | EDC | eCOA), Clinical Operations (Trial Disclosure | SUSAR Reporting | eTMF), CTMS, Site Payments, Medical Affairs Platform, Global Medical Information Management, Medical Content Management, Mobile Adverse Event Reporting, Product Complaint Management, Regulatory Publishing, Document Management, and Automation
Locations
Employees at ArisGlobal
-
Mike Griffin
Head of UX Design
-
Jay Zipursky
UX Strategy, Research, and Design
-
Amrit Ray, M.D.
Board Chairman & Director • Physician Researcher and Advocate for Healthcare Access • Former Global President, Head of R&D and Medical, Pfizer
-
Eric Jensen
Healthcare Operator | Investor | Innovator
Updates
-
At World Drug Safety Congress Americas this week, ArisGlobal's Morgan Waller Scott caught up with CEO Aman Wasan and Chairman of the Board Amrit Ray, M.D. after their opening keynote fireside chat. Hear what both leaders had to say about overcoming economic and industry pressures with the strategic application of #GenAI throughout the R&D IT ecosystem, how ArisGlobal is customizing our solutions to address these challenges, and what both are hopeful for as we look to the future of Safety technology. #lifesciences #pharma #drugsafety
-
It's time to discover the value your Safety platform can deliver - and that starts by going beyond the status quo to embrace the next generation of #pharmacovigilance innovation. 💡 Discover the 6 major ways firms are realizing the value of their PV investments with LifeSphere Safety below, and learn more here: https://lnkd.in/ersujgKr #drugsafety #safetyoperations #pv #pvautomation #lifesciences #pharmatech
-
-
The life sciences industry is harnessing the power of AI to drive true transformation. In a new article for Forbes, our CEO Aman Wasan breaks down how life sciences is leading from the front on compliance and leveraging groundbreaking, advanced applications of AI - and how early adopters are already seeing measurable gains in efficiency and accuracy that indicate a promising future. Read the full article here: https://lnkd.in/ezTh4gyW #GenAI #LLMs #drugsafety #regulatoryoperations #lifesciences #pharma #biopharma #forbescouncil
What happens when a typically risk-cautious industry starts embracing cutting-edge AI? A transformation we can't ignore. Historically, the biopharmaceutical industry has rightfully prioritized safety and compliance, often at the expense of speed. But by harnessing powerful tools like Generative AI and Large Language Models (LLMs), leading organizations are shifting this paradigm - bringing safer, more effective treatments to patients faster and more cost-effectively. In fact, our recent survey data at ArisGlobal shows that over two-thirds of biopharma R&D teams already see productivity and accuracy gains from automation—clear evidence of the potential impact ahead. I invite you to read my first piece as a member of the Forbes Technology Council to learn more about why the life sciences are indeed the industry to watch for its application of advanced AI-driven capabilities: https://lnkd.in/eQ8r9k7V #lifesciences #genai #automation #drugsafety #pharma #compliance #llms
-
-
Mic check🎙️ We've got big news to share: meet the Life Sciences GenAI Exchange Podcast, a brand new podcast series diving deep into the transformative impact of generative AI and automation in life sciences. https://lnkd.in/eEJgp_Zt In Episode 1, host Jason Bryant welcomes Nordic Capital's Daniel Berglund and ArisGlobal's Aman Wasan to discuss key economic challenges facing the life sciences industry today, with actionable insights for organizations seeking to streamline R&D workflows, enhance innovation, and enable cost savings through tools like #GenAI. Tune in on Apple Music or Spotify to hear the first episode NOW - and stay tuned for future conversations with expert industry leaders as we uncover how technology is shaping innovation across the pharmaceutical industry. #lifesciences #drugsafety #regulatoryoperations #genai #automation #advancedautomation #drugdevelopment
-
-
World Drug Safety Congress Americas is underway in Boston, MA and ArisGlobal has shown up in full force. This morning began with an insightful fireside keynote discussion from CEO Aman Wasan and Chairman of the Board Amrit Ray, M.D. focused on overcoming economic and industry pressures with the strategic application of #GenAI throughout the R&D IT ecosystem. Plus, the excitement continues into the evening at ArisGlobal After Hours, featuring an evening of entertainment, networking, and stunning harbor views. You can still RSVP to join us in just a few hours: https://lnkd.in/eCTnMvwy P.S. - be sure to join us tomorrow for our opening keynote panel moderated by CIO & Global Head of R&D Ann-Marie Orange about the importance of safeguarding your Safety technology investment, featuring expert panelists from Bristol Myers Squibb, Amgen, Astellas, Opella, and Johnson & Johnson. This is a can't-miss session! #WDSUS #WorldDrugSafety #AGAfterHoursUS #lifesciences #drugsafety
-
-
Mark your calendars! 🗓️ On November 12th, join us for an insightful panel discussion where global leaders in pharmaceutical IT and pharmacovigilance will share their expertise on getting the most value out of their technology investments, including significant efficiency and cost savings. Attendees will hear about real-world applications and actionable takeaways from Astella's Ellen Mishalov and Merck's Claudia Schaffer - including setting clear goals, advocating for ongoing investment in new technologies, and maximizing the value delivered via investments in pharmacovigilance technology. Don't wait - claim your spot and RSVP now! #lifesciences #safety #drugsafety #pharmacovigilance
This content isn’t available here
Access this content and more in the LinkedIn app
-
Snapshots from Day 1 of DIA Japan 📸 We’re looking ahead to this afternoon's Luncheon Seminar to learn more about cutting through #GenAI hype to generate true ROI for Safety systems, featuring ArisGlobal’s Vice President, Japan Operations Krishana Gopal Das and Solution Consultant, APAC Dr. Dapeng Jiang. If you're in Tokyo for #DIAJapan this week, don't forget to stop by booths 26 & 27 to meet with our fantastic team and learn more about innovative LifeSphere technologies. #lifesciences #dia #drugsafety #lifesphere #DIAJapan2024
-
-
ArisGlobal is in Tokyo this week for the 21st DIA Japan Annual Meeting 2024! Stop by booths 26 and 27 to learn more about our next generation LifeSphere technology suite, and don’t miss our luncheon seminar on October 28th at 1:20pm. 📆 In this must-attend session, ArisGlobal’s own Vice President, Japan Operations Krishana Gopal Das and Solution Consultant, APAC Dr. Dapeng Jiang, will share specific use cases of LifeSphere technology, showcasing how #Automation and #GenAI can optimize data management and enhance the efficiency of safety systems, delivering immediate return on investment (ROI). #DIAJapan #DIAglobal #lifesciences #drugsafety
-
-
Regulatory Affairs is a rapidly evolving landscape - and new advancements and trends are continually shaping the future. Is your organization tapped in for success? Explore our deep dive into the latest developments in Regulatory Affairs to stay ahead of the curve and expect what's next: https://lnkd.in/e-ZHjr-4 #RegulatoryAffairs #LifeSciences #PharmaTech #Innovation #Compliance #RegulatoryTrends #HealthTech
-